Göğşen Önalan

ORCID: 0000-0003-3446-3751 · 14 papers in corpus
case-report 2026
Journal of the Turkish German Gynecological Association ·doi:10.4274/jtgga.galenos.2025.2025-10-5

We present a rare Müllerian anomaly known as "accessory cavitated uterine mass (ACUM)," which causes severe, refractory dysmenorrhea, and review the literature. A 17-year-old patient experienced severe, cyclic left-sided pelvic pain, correl…

observational 2025
Journal of the Turkish German Gynecological Association ·doi:10.4274/jtgga.galenos.2025.2025-9-11

ObjectiveTo evaluate the oncological and reproductive outcomes of patients with ovarian sex-cord stromal tumors (SCSTs) treated with fertility sparing surgery (FSS).Material and methodsThis retrospective study included patients diagnosed wi…

other 2017
Gynecologic and obstetric investigation ·doi:10.1159/000484895

AIMS: To determine the effects of a tumor necrosis factor inhibitor (etanercept) on pregnancy outcomes in patients with endometrioma who were treated with assisted reproductive technology. METHODS: Sixty-eight infertile patients who had en…

2015
·doi:10.1016/j.fertnstert.2015.07.650
other 2013
Archives of gynecology and obstetrics ·doi:10.1007/s00404-013-2963-0

PURPOSE: To assess the effects of amifostine, N-acetyl cysteine (NAC), and leuprolide as a scavenger in a rat endometriosis model. METHODS: This is a prospective randomized animal study. Setting The Animal Laboratory of Medical University.…

lab-animal 2009
Human Reproduction ·doi:10.1093/humrep/dep106

BACKGROUND: Doxycycline (Dox) has a number of non-antibiotic properties. One of them is the inhibition of matrix metalloproteinase (MMP) activity. The aim of this study was to assess the effects of Dox in a rat endometriosis model. METHODS…

lab-animal 2009
Fertility and sterility ·doi:10.1016/j.fertnstert.2009.05.065

Fenofibrate -a peroxisome proliferator-activated receptor-a agonist- is an angiostatic agent that is commonly used in human liver diseases, therefore it may interfere with the angiogenetic process required for endometriosis. In a rat endome…

2008
·doi:10.1016/j.fertnstert.2008.07.1140
2007
·doi:10.1016/j.fertnstert.2007.07.707
2007
·doi:10.1016/j.fertnstert.2007.07.708
rct 2007
Fertility and sterility ·doi:10.1016/j.fertnstert.2006.12.046

OBJECTIVE: To investigate the outcomes of intracytoplasmic sperm injection (ICSI) cycles after controlled ovarian hyperstimulation (COH) with GnRH antagonist or GnRH agonist (GnRH-a) in mild-to-moderate endometriosis and endometrioma. DESI…

2005
·doi:10.1016/j.fertnstert.2005.07.496
observational 2005
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2005.08.002

OBJECTIVE: To determine follicular fluid (FF) and serum levels of soluble Fas (sFas) and soluble Fas ligand (sFasL) in patients undergoing IVF cycles. STUDY DESIGN: A prospective comparative study among patients with endometriosis (n=12), …

nonrandomized-trial 2004
Fertility and sterility ·doi:10.1016/j.fertnstert.2004.02.117

OBJECTIVE: To investigate whether aspiration of ovarian endometriomas before controlled ovarian stimulation (COH) improves intracytoplasmic sperm injection (ICSI) outcomes. DESIGN: Prospective study. SETTING: University hospital. PATIENT…